Global Nicotinamide Markets Show Marginal Gains of 0.4% as Normalization Continues

The global market of Nicotinamide (Vitamin B3) has continued its steady normalization in early November 2025. The market normalization was in continuation from October after the sharp surge of more than 3.5% in September. The prices of Nicotinamide have registered modest increase. The market increase has reflected a controlled upward adjustment rather than volatile swings. The sustained demand from the downstream sectors like personal care, cosmetics and nutraceuticals have supported the gradual uptrend. The suppliers of Nicotinamide have maintained strategic prices and the buyers have managed their inventories. The procurers have drawn on buffers secured in previous procurement cycles which kept the increase in the market limited. The efficient production runs by the manufacturers have ensured consistent supply which prevented the market tightness. The seasonal anticipation of higher offtake during the winter months have also contributed to the measured increase. ChemAnalyst anticipates that the prices will likely maintain an upward trajectory in the forthcoming period.